Biotage AB (Sweden) Analysis
| BIOT Stock | SEK 143.00 0.10 0.07% |
Biotage AB is fairly valued with Real Value of 143.61 and Hype Value of 143.0. The main objective of Biotage AB stock analysis is to determine its intrinsic value, which is an estimate of what Biotage AB is worth, separate from its market price. There are two main types of Biotage AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biotage AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biotage AB's stock to identify patterns and trends that may indicate its future price movements.
The Biotage AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Biotage AB is usually not traded on Good Friday, Epiphany, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day. Biotage Stock trading window is adjusted to Europe/Stockholm timezone.
Biotage |
Biotage Stock Analysis Notes
About 65.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 29th of April 2022. Biotage AB had 209:202 split on the 27th of October 2005. Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 438 people. For more info on Biotage AB please contact Tomas Blomquist at 46 18 56 59 00 or go to https://www.biotage.com.Biotage AB Investment Alerts
| About 65.0% of the company shares are held by institutions such as insurance companies |
Biotage Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 10.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotage AB's market, we take the total number of its shares issued and multiply it by Biotage AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biotage Profitablity
Biotage AB's profitability indicators refer to fundamental financial ratios that showcase Biotage AB's ability to generate income relative to its revenue or operating costs. If, let's say, Biotage AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biotage AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biotage AB's profitability requires more research than a typical breakdown of Biotage AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Technical Drivers
As of the 21st of July, Biotage AB shows the Coefficient Of Variation of 731.0, risk adjusted performance of 0.1364, and Mean Deviation of 1.73. Biotage AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biotage AB Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Biotage AB for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Biotage AB short-term fluctuations and highlight longer-term trends or cycles.
Biotage AB Outstanding Bonds
Biotage AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biotage AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biotage bonds can be classified according to their maturity, which is the date when Biotage AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Biotage AB Predictive Daily Indicators
Biotage AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotage AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biotage AB Forecast Models
Biotage AB's time-series forecasting models are one of many Biotage AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotage AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biotage Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biotage AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotage shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biotage AB. By using and applying Biotage Stock analysis, traders can create a robust methodology for identifying Biotage entry and exit points for their positions.
Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 438 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biotage AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Additional Tools for Biotage Stock Analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.